These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

393 related items for PubMed ID: 25678241

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Reports of cell-based influenza vaccine administered during pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 2013-2020.
    Moro PL, Marquez P.
    Vaccine; 2021 Jan 22; 39(4):678-681. PubMed ID: 33358703
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System, 1990-2009.
    Moro PL, Broder K, Zheteyeva Y, Walton K, Rohan P, Sutherland A, Guh A, Haber P, Destefano F, Vellozzi C.
    Am J Obstet Gynecol; 2011 Feb 22; 204(2):146.e1-7. PubMed ID: 20965490
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Safety, immunogenicity and shedding of LAIV4 in HIV-infected and uninfected children.
    Curtis D, Ning MF, Armon C, Li S, Weinberg A.
    Vaccine; 2015 Sep 11; 33(38):4790-7. PubMed ID: 26241950
    [Abstract] [Full Text] [Related]

  • 30. Adverse events following pandemic influenza A (H1N1) 2009 monovalent and seasonal influenza vaccinations during the 2009-2010 season in the active component U.S. military and civilians aged 17-44years reported to the Vaccine Adverse Event Reporting System.
    Bardenheier BH, Duderstadt SK, Engler RJ, McNeil MM.
    Vaccine; 2016 Aug 17; 34(37):4406-14. PubMed ID: 27449076
    [Abstract] [Full Text] [Related]

  • 31. Safety of quadrivalent live attenuated influenza vaccine in subjects aged 2-49years.
    Baxter R, Eaton A, Hansen J, Aukes L, Caspard H, Ambrose CS.
    Vaccine; 2017 Mar 01; 35(9):1254-1258. PubMed ID: 28162825
    [Abstract] [Full Text] [Related]

  • 32. Data mining for prospective early detection of safety signals in the Vaccine Adverse Event Reporting System (VAERS): a case study of febrile seizures after a 2010-2011 seasonal influenza virus vaccine.
    Martin D, Menschik D, Bryant-Genevier M, Ball R.
    Drug Saf; 2013 Jul 01; 36(7):547-56. PubMed ID: 23657824
    [Abstract] [Full Text] [Related]

  • 33. Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices--United States, 2013-2014.
    Centers for Disease Control and Prevention (CDC).
    MMWR Recomm Rep; 2013 Sep 20; 62(RR-07):1-43. PubMed ID: 24048214
    [Abstract] [Full Text] [Related]

  • 34. Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring.
    Vellozzi C, Burwen DR, Dobardzic A, Ball R, Walton K, Haber P.
    Vaccine; 2009 Mar 26; 27(15):2114-20. PubMed ID: 19356614
    [Abstract] [Full Text] [Related]

  • 35. Adverse events after tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine administered to adults 65 years of age and older reported to the Vaccine Adverse Event Reporting System (VAERS), 2005-2010.
    Moro PL, Yue X, Lewis P, Haber P, Broder K.
    Vaccine; 2011 Nov 21; 29(50):9404-8. PubMed ID: 21920404
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.
    Piedra PA, Gaglani MJ, Kozinetz CA, Herschler GB, Fewlass C, Harvey D, Zimmerman N, Glezen WP.
    Pediatrics; 2007 Sep 21; 120(3):e553-64. PubMed ID: 17698577
    [Abstract] [Full Text] [Related]

  • 39. Live Attenuated and Inactivated Influenza Vaccine Effectiveness.
    Chung JR, Flannery B, Ambrose CS, Bégué RE, Caspard H, DeMarcus L, Fowlkes AL, Kersellius G, Steffens A, Fry AM, Influenza Clinical Investigation for Children Study Team, Influenza Incidence Surveillance Project, US Influenza Vaccine Effectiveness Network.
    Pediatrics; 2019 Feb 21; 143(2):. PubMed ID: 30617239
    [Abstract] [Full Text] [Related]

  • 40. Postmarketing safety surveillance of trivalent recombinant influenza vaccine: Reports to the Vaccine Adverse Event Reporting System.
    Woo EJ, Moro PL, Cano M, Jankosky C.
    Vaccine; 2017 Oct 09; 35(42):5618-5621. PubMed ID: 28886946
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.